Abstract:OBJECTIVE:To explore the expression of antigen activated of macrophages (MPhi) of bone marrow and its clinical significance in pancytopenia patients with positive bone marrow mononuclear cells (BMMNC)-Coombs test (immunorelated pancytopenia, IRP). METHODS:Sixty-one IRP patients, 10 severe aplastic anemia (SAA) patients and 13 healthy controls were enrolled in this study. The categories of auto-antibodies (IgG, IgM) on BMMNC (CD(34)(+)/CD(15)(+)/GlycoA(+) hematocytes), the quantity (CD(68)(+)/CD(45)(+))% and expression of antigen activated (CD(69)) of MPhi (CD(68)(+)CD(69)(+)/CD(+)(68))% in bone marrow of all cases and controls were measured by fluorescence activated cell sorting (FACS). RESULTS:The quantity and expression ratio of activated antigen of bone marrow (BM) MPhi in IRP patients [(0.57 +/- 0.30)% and (40.30 +/- 18.49)%] were respectively significantly higher than those in SAA [(0.46 +/- 0.08)% and (32.44 +/- 19.37)%] and healthy controls [(0.44 +/- 0.69)% and (29.71 +/- 11.67)%] (both P < 0.05). The quantity presented high-positive correlation with the expression ratio of activated antigen of BM MPhi (r = 0.89, P < 0.01). Patients with IRP were classified into two subgroups according to the quantity of MPhi: Group A (MPhi >/= 0.5%, 34 cases) and Group B (MPhi < 0.5%, 27 cases). Thirty-two cases (94.12%) were with auto antibody (IgG) in Group A, while only 2 (7.41%) with auto antibody (IgG) in Group B. There was significant difference in expression ratio of activated antigen of BM MPhi between Group A (49.19 +/- 16.63)% and Group B (29.11 +/- 14.30)% (P < 0.05), but no difference was found between Group B and the control group (P > 0.05). Total curative rates at 3 and 6 month (47.06% and 79.41%) of Group A were better than those of Group B (22.22% and 51.85%). Thirty-four IRP patients with autoantibody (IgG)(+) were divided into two subgroups according to the quantity of MPhi: high level group (>/= 0.75%, 9 cases) and low level group (< 0.75%, 25 cases), 24 cases (96%) in MPhi low level group were found auto-antibody (IgG) on one hemotopoietic cell lineage, 1 on two lineages, while 8 (88.89%) in MPhi high level group were detected auto-antibody (IgG) on two cell lineages, and 1 on three cell lineages. Expression ratio of activated antigen (56.12 +/- 15.11)% was much higher in MPhi high level group than that in MPhi low level group (44.58 +/- 18.16)% (P < 0.05). The count of red blood cell concentration of hemoglobin and platelet in peripheral blood in MPhi high level group were respectively lower than those in MPhi low level group, while the percentage of Ret, the level of total bilirubin and indirect bilirubin, the ratio of erythroid of sternal bone marrow in MPhi high level group were higher than those in MPhi low level group. CONCLUSION:The expression of activated antigen of BM MPhi was enhanced in IRP especially with auto-antibody (IgG), which might be involved in damage process of hemotopoietic cell.

[Expression of Bone Marrow Macrophages Antigen Activation and Its Clinical Significance in Pancytopenia Patients with Positive Bone Marrow Mononuclear Cells-Coombs Test.].

[Study on Quantity and Function of Bone Marrow Macrophages in Patients with BMMNC-Coombs Test(+) Pancytopenia].

[Study of the Quantity and Function of Th17 Cells in the Blood Cytopenic Patients with Positive BMMNC-Coombs Test].

[Category, Quantity and Clinical Significance of Autoantibodies on Bone Marrow Hematopoietic Cells in Patients with Immunorelated Cytopenia].

Clinical Analysis of 72 Cases of Immunorelated Pancytopenia with Positive BMMNC-Coombs Tests

Preliminary study on the quantity and function of T follicular helper cells in the cytopenic patients with positive BMMNC-Coombs test

Increased Frequency of Bone Marrow T Follicular Helper Cells in Patients with Immune-Related Pancytopenia

[Proliferation of Bone Marrow Hematopoietic Stem Cells and Function of T Helper Lymphocytes of Patients with Immuno-Related Pancytopenia].

[Quantity and Function of Regulatory T Cells in Hemocytopenic Patients with Positive BMMNC-Coombs Test].

Detection and Analysis of Autoantigens Targeted by Autoantibodies in Immunorelated Pancytopenia.

Memory B (CD5+CD19+CD27+) lymphocyte in patients with immune-related pancytopenia

[Expressions of CD117 and CD11b in Patients with APL at Diagnosis and Post-Treatment].

Effectiveness of Bacterial Infection-Related Cytokine Profile (BIRCP) Determination for Monitoring Pathogen Infections in Children with Hemopathy in the Bone Marrow Inhibition Phase.

P768: PRELIMINARY EXPLORATION ON LAG-3 EXPRESSION OF BONE MARROW-DERIVED MACROPHAGES IN SEVERE APLASTIC ANEMIA

Quantity and subtypes of dendritic cells in patients with immune related pancytopenia and their clinical significance]

Erythropoietin Receptors And Igg Autoantibody Expression On Nucleated Erythrocytes In Some Cases Of Immuno-Related Pancytopenia

Cytokine Consistency Between Bone Marrow and Peripheral Blood in Patients with Philadelphia-Negative Myeloproliferative Neoplasms

[Changes of Transcription Factors Bcl-6, Foxp3 and RORγt in CD4(+) Cells in Bone Marrow of Immuno-Related Hematocytopenia].

Study on the Membrane Hemopoietic Cytokine Receptor Expression on Cd34+Bone Marrow Cells of the Patients with Myelodysplastic Syndromes

[Quantity and Apoptosis-Related Protein Level of B Lymphocyte in Patients with Immunorelated Pancytopenia].

[Characteristic and Function of Peripheral Blood Mononuclear Cells-Induced Macrophages in Patients with Myelodysplastic Syndrome].